Accredation: 25 CME From NHRA - Bahrain

Date: 8-9-10-11 October 2020

Patient Safety: An Emphasis on Prevention and Control of Infection Conference

INTRODUCTION

Patient Safety is the center of every healthcare quality initiatives. Prevention and Control of Infection (PCI) is an indispensible component of patient safety discipline and early PCI pioneers promoted patient safety. For example Ignaz Semmelweis reduced maternal mortality through hand washing while his understanding of microbiology compared to today’s knowledge of microbiology was ignorable. Florence Nightingale minimized infections in wards during the Crimean war by rigorous environmental cleanliness and Joseph Lister in England insisted on antisepsis in surgery and reduced surgical site infections.

In they 21st century, despite all scientific progresses, patient safety is not only a dilemma in low and middle-income countries rather; it is a problem in industrial world too. For example, in low- and middle-income countries, between 5.7 and 8.4 million deaths occur each year and the costs of lost productivity alone amount to between $1.4 and $1.6 trillion each year.

In industrialized countries, the problem is also noticeable. In the US for example, the cost of patient safety have totaled almost $9 billion. In the UK, the NHS Litigation Authority in England pays over £633 million in settlement of clinical negligence claims annually. Globally, only medication errors have been estimated at $42 billion annually.

To lay stress on PCI as an important component of patient safety published data is staggering. Approximately 1 in 10 hospitalised patients will acquire an infection after admission, resulting in substantial economic cost. Annual financial losses due to health care-associated infections (HAIs) are also significant:they are estimated at approximately €7 billion in Europe, including direct costs onlyand reflecting 16 million extra days of hospital stay. Similar cost in the US is about US$ 6.5 billion.

These figures show the tip of the iceberg. For this reason, focusing on patient safety in general and PCI in particular are the only way to save billions of dollars and millions of lives globally and minimize medicolegal claims. PCI and its importance in relationship to patient safety will be discussed as a major part of the webinar.




Conference President’s Welcome Message

Distinguished delegates, colleagues in healthcare, ladies and gentlemen,

It is a great pleasure to address an audience committed to advancing safe, high-quality clinical care for all patients, rich and poor both now and in the future.

I thank the speakers, session moderators, sponsors and more importantly our Strategic partners, the Ministry of Health and National Healthcare Regulatory Authority of Kingdom of Bahrain. I would like to thank my colleagues of King’s Centre for professional Development and of BDA Conferences & Exhibitions and Scientific Committee, organizing Committee & Support Committee.

The conference is being held at an impactful time for GCC countries as the first Patient Safety Conference in the Kingdom of Bahrain. For many reasons concern about the quality and safety of patient care is reaching new heights. The WHO 72nd World Health Assembly, in May 2019 with the adoption of resolution WHA72 announced 17 September as The World Patient Safety Day. It is a great achievement that we are attending the First Patient Safety & Prevention & Control of Infection in 2020 in the GCC region to be streamed from the Kingdom of Bahrain. I congratulate the Bahraini Health Authorities for this achievement.

Patient safety is a comparatively new discipline that has rapidly risen to star status. This rise began in late 1999, with the eye-opening report of “To Err Is Human: Building a Safer Health System” in November 1999 by the U.S. Institute of Medicine that may have resulted in increased awareness of U.S. medical errors.

Let me conclude my opening speech by mentioning these facts that up to 4 out of 10 patients are harmed in primary and ambulatory care settings. This translates to 134 million adverse events each year in hospitals worldwide and contributing to 2.6 million deaths annually due to unsafe care worldwide. In addition, medication errors cost an estimated 42 billion USD annually.

I would like to take this opportunity again to congratulate our partners for supporting such an important conference.

I warmly welcome you to this conference and wish you all a most enjoyable and successful event. Thank you.

Professor Lesley Hunter

  • Conference President
  • B.Sc (Hons), BA, PGCE, DProf, Fpsa, FInstLM
  • Rt Faculty, SBS Swiss Business School, Switzerland

Scientific Committee Chairman Welcome Message

Madam President, dear distinguished guests, colleagues’ ladies and gentlemen

On behalf of the Scientific Committee colleagues I express my deepest gratitude to the seminar organisers and sponsors to be entrusted with the responsibility of development of scientific programme. My colleagues have worked hard to create an interesting and blended scientific programme that should meet your expectation and attract your attention with. This may not be easy as each of you is experienced in a field of healthcare continuum.

I am proud that the scientific committee has succeeded to invite a large number of internationally sought-after speakers from different disciplines of healthcare. It is also an honour to be part of a team whose responsibility is creating a very well-seasoned programme of Patient Safety just one year after the WHO 2019 announcement of the World Patient Safety Day. I would be unfair if I do not say that the credit of success also goes to the Ministry of Health of Kingdom of Bahrain and National Healthcare Regulatory Agency (NHRA) colleagues who tirelessly supported us to convene the first seminar of its own kind in the GCC countries. This clearly shows the leading role and strong commitment of the Kingdom in promoting Patient Safety.

We are excited not only to introduce the first seminar on Patient Safety after the WHO announcement but also to promote the important concept of Patient Safety as the main focus of implementation of quality principles in healthcare.

We are fortunate to have with us, speakers from all over the world to share their invaluable experience and perspectives on the topic. The committee members sincerely wish to be able to convene a Patient Safety seminar annually to celebrate the World Patient Safety Day; an important day which has a strong root in the first historic report of the Institute of Medicine on Patient Safety in the United States. I refer to the milestone report entitled: ‘To Err is Human: Building a Safer Health System’ in September 1999. Since then, undoubtedly, we have made a great progress worldwide on Patient Safety, but it is not enough yet since as many as 251,000 people annually die of medical errors only in the United States..

e hope this 4-day programme- with dedication of the first day to COVID-19- will be memorable and beneficial to all our attending colleagues. May the exposure you receive here could fuel further enthusiasm and interest in Patient Safety for a safer healthcare environment that we are creating for the present and the future generations. Thank You

Professor Farry Bruce Jeffrey, UK

  • Scientific Committee Chairman
  • M.Med. Sci. (Clin Path), Ph.D. (Med Micro), FIMBS, Dip (Change Mngt), CPTQM,
  • IOSH Cert of Health & Safety Management; Patient Safety Certificate (USA), European Union Law Certificate

Scientific Committee

Professor Farry Bruce Jeffrey

Scientific Committee Chairman
M.Med. Sci. (Clin Path), Ph.D. (Med Micro), FIMBS, Dip (Change Mngt), CPTQM, IOSH Cert of Health & Safety Management; Patient Safety Certificate (USA), European Union Law Certificate.

Professor Mohamed NA Abdelhakim

Scientific Committee Co-Chairman
BA, M.Sc., Ph.D, Professor of Management Information Systems, M.Sc. Program Director of Information Systems Security at University of Modern Sciences-Dubai, UAE.

Dr Jameela Al-Salman

Scientific Committee Member
Member of the national medical taskforce combating COVID 19, kingdom of Bahrain, Senior Consultant in Infectious diseases and Consultant in geriatric medicine, Chairperson of the national antibiotic stewardship committee, kingdom of Bahrain

Dr Nehad Nabeel Al Shirawi

Scientific Committee Member
MD, MRCP (UK), EDIC, SAUDI FELLOWSHIP (ICU).,PROF DIP (Health Admin).,Consultant ICU & Pulmonologist, Adjunct Professor Chair of the National Antibiotic Stewardship Program, UAE.

Dr Maha Khalid Almazroua

Scientific Committee Member
PharmD, MSc Toxicology & Forensic Sciences.,PhD in Quality Management.,Director pf the regional poison control center-Ministry of Health, Saudi Arabia,Chief of Eastern Provence Pharmacist Club (EPPC) , Saudi Pharmaceutical Society SPS, Saudi Arabia

Dr Alaa Zidan

SScientific Committee Member
Mb Chb college of medicine-Alexandria University, Egypt.,M.Sc. Orthopaedic and Trauma College of Medicine,Cairo University, Egypt,Senior lecturer Medical college Arab Gulf University, kingdom of Bahrain.,Consultant Health and Safety Almashraq Training, kingdom of Bahrain.

Timing:

2.00 p.m. till 8.00 p.m. (Bahrain & Saudi Arabia Time)
3.00 p.m. till 9.00 p.m. (UAE & Oman Time)

Live Streaming on www.bdacenter.net/webinar Registration fees:

Registration Categories Fees
Physician/Pharmacist 50 BD / 500 SR
Physician /Pharmacist - MOH/COVID-19 frontliner * 40 BD / 400 SR
Medical Allied/Nurse/Student/Technician 30 BD / 300 SR
Medical Allied/Nurse/Student/Technician - MOH/BMS/COVID-19 frontliner * 25 BD / 250 SR
* Ministry of Health Employee- Bahrain / COVID-19 front liner: healthcare profession working around the world to combat coronavirus


Registration fees includes:

1. Secured Access to the full programs (A 4-day conference)
2. Congress Certificate with 25 CME/CPD Points from NHRA, Bahrain
3. Certificate of Training on COVID-19 from King’s Centre for Professional Development.
4. Discounted Tuition Fees (20%) for Professional Diploma in Infection Control from American university in RAK-UAE.


LEARNING OUTCOME:

• Gain insights into current developments in patient safety as an important element within patient safety.
• Discuss the patient safety and future priorities and learning how they apply to your organization.
• Assess how to develop and successfully implement a just culture based on learning and reliability.
• Understand the need to improve investigations and develop more consistent regulation in patient safety.
• Attend workshops discussing current priorities for patient safety and share insights into progress and next steps.
• Learn about the role of Patient Safety Collaborative and the importance of partnership that is transferable to your locality.
• Discuss with colleagues the importance of involving and engaging patients in helping to improve services and ensure quality improvement in healthcare.
• In-depth understanding of PCI as an vitally important component of patient safety from across different sectors.
• Network with colleagues, share experiences and contribute to wider thinking on improving patient safety and PCI in all healthcare settings.


Targeted Audience:

• Quality Directors
• Heads of Patient Safety
• Medical Directors
• Nursing Directors
• Chief Executives
• Directors of Infection Prevention and Control
• Infection Control Lead Practitioners
• Specialist Nurses
• Heads of Pharmacy
• Surgeons
• Risk Managers
• Patient Safety, Quality and Risk Management Enthusiasts
• Academics/Researchers


Speakers:


View All Speakers


TimeTable: